<DOC>
	<DOCNO>NCT02561299</DOCNO>
	<brief_summary>The purpose study prospectively evaluate acute long term clinical result orbital atherectomy ( OA ) adjunctive drug coat balloon ( DCB ) angioplasty versus DCB angioplasty alone treatment Peripheral Artery Disease ( PAD ) knee ( BTK ) lesion .</brief_summary>
	<brief_title>Orbital Vessel PreparaTIon MaximIZe Dcb Efficacy Calcified Below Knee ( BTK ) Lesions - A Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Calcinosis</mesh_term>
	<mesh_term>Vascular Calcification</mesh_term>
	<criteria>Subject 's age ≥ 18 year Rutherford Clinical Category 3 5 Lesions [ except instent restenosis ( ISR ) ] distal popliteal ( POP segment anatomical knee joint ) , anterior tibial , posterior tibial , tibial peroneal trunk , peroneal artery ≥ 70 % diameter stenosis ( DS ) angiography Presence clearly visible calcification two view ( side vessel location ) evaluate angiographically Length calcium ≥ 50 % total lesion length Target lesion length 20 cm Subject subject 's legal representative willing sign Ethics Committee approve informed consent form comply study protocol requirement Contraindicated either device , per Instructions For Use Presence inflow lesion ( ≥ 50 % DS ) inflow successfully treat ( ≥ 50 % DS and/or unresolved significant angiographic complication ) Compromised outflow distal target lesion ( ≥ 70 % DS ) presence lesion ( ) occlusion ( ) locate 5 cm ankle ankle joint space Subject 2 target vessel require treatment The guide wire pass across target lesion ( ) and/or guide wire position distal target lesion ( ) outside vessel lumen Presence significant ( ≥ 70 % DS ) lesion ( ) occlusion ( ) meeting study criterion successfully treat index procedure ( ≥ 50 % DS and/or significant angiographic complication ) Subject plan amputation ( include minor ) index limb previous major amputation contralateral limb Creatinine &gt; 2.5 mg/dL , unless dialysis Subject significant medical condition , Investigator 's opinion , may interfere subject 's optimal participation study Subject participate investigational drug device study potential clinically interfere study outcome measure Subject pregnant planning become pregnant within study period Subject unresolved severe systemic infection Subject anticipate life span less one year Subjects know hypersensitivity paclitaxel paclitaxel related compound Subjects receive recommend antiplatelet and/or anticoagulant therapy Predilatation target lesion prior randomization OA treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Drug-coated Balloons</keyword>
	<keyword>Calcified Lesions</keyword>
	<keyword>Orbital Atherectomy</keyword>
	<keyword>Below Knee</keyword>
	<keyword>Paclitaxel</keyword>
	<keyword>Lutonix 014 Drug-coated Balloon</keyword>
</DOC>